Chi-Hien Dang*a,
Cong-Hao Nguyena,
Thanh-Danh Nguyen*ab and
Chan Imb
aDepartment of Pharmaceutical Chemistry, Institute of Chemical Technology, VAST, Vietnam. E-mail: dangchihien@gmail.com; Tel: +84 8 38238265
bDepartment of Chemistry, Konkuk University, Korea. E-mail: danh5463bd@yahoo.com; Tel: +82 2 4503415
First published on 20th December 2013
Novel 1,3,4,6-tetra-O-acyl-N-acyl-D-glucosamine derivatives were synthesized from glucosamine hydrochloride (GlcN·HCl) by the acylation with pyridine as a catalyst. A derivative of tetra-O-acetyl glucosamine contained ketoprofen, a non-steroidal anti-inflammatory drug (NSAID) with analgesic and antipyretic effects, was first synthesized. In analysis of the NMR spectra, the ratio of α:β-anomer showed that penta-acyl-D-glucosamine derivatives and N-acetylated glucosamines containing O-acyl groups have been only the α-anomer. Meanwhile, both the intermediates and the glucoconjugate compound of ketoprofen have only the β-anomer.
NSAIDs17–19 have also been used in the treatment of rheumatoid arthritis. In this purpose, Numerous NSAIDs ester derivatives have been synthesized to reduce gastro intestinal side-effect. It was also known that glucoconjugates could be transported by cellular glucose transporters. Therefore, the glucoconjugates of NSAIDs were recently prepared with the objective of increasing the bioavailability of antioxidant and anti-inflammatory drugs such as, ibuprofen,20 aspirin, diclofenac and indomethacin.21,22 These findings indicated that the glucoconjugates of NSAIDs might lead to reduce ulcerogenic potency, increase bioavailability and possess coordinative effects on osteoarthritis.
Some acyl derivatives of this amino sugar with fatty acids have been previously reported in the literature.14,15,23 However, their NMR spectra data has not revealed whether or not influence of N- and O-substituted groups to the α:β-isomer ratio of these derivatives. Our initial research24 revealed that the short fatty acid groups have been giving the isomer ratio by the rules. In this paper, we describe the synthesis and NMR spectral data analysis of a series penta-acyl-D-glucosamine, 1,3,4,6-tetra-O-acyl-N-acyl-D-glucosamine derivatives and a novel glucoconjugate of ketoprofen, which is prepared from GlcN·HCl. In synthesis of the glucoconjugate compound, a series of the compounds containing O-acetyl groups was also prepared.
The synthesis of glucoconjugate of NSAIDs has been described by different methods using various acetylated glucosamine analogues as glycosyl donors.12,21 A synthesis of 18 from GlcN·HCl using esterification of NH2 of glucosamine by ketoprofen chloride12 and followed the acetylation of all four OH groups of sugar ring by acetic anhydride was attempted. However, in our experiment, ketoprofen chloride as a key intermediate obtained from ketoprofen and thionyl chloride were synthesized in a low yield. Alternatively, the use of 1,3,4,6-tetra-O-acetyl-β-D-glucosamine hydrochloride (17) as a glycosyl donor12,25 gave good yield as described in Scheme 2.
Compound 16 was obtained from commercially available GlcN·HCl in a procedure that used p-anisaldehyde for protection of –NH2 group in 67.82% yield. Acetylation and removal of the p-methoxybenzylidene group with HCl in acetone were to give 17 in 91.3% yield. The ester 18 was obtained by esterifying ketoprofen with amine glycosyl compound 17 in the presence of DCC/DMF–Py–Et3N in 51.5% yield after purification by silica gel column chromatography.
Sugar moiety | N–H | Acyl groups | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
H-1 | H-2 | H-3 | H-4 | H-5 | H-6 | ||||||
H-6a | H-6b | N-acyl | O-acyl | ||||||||
a NMR experimental conditions: 500 MHz, CDCl3. | |||||||||||
5 | 6.19 (d, 3.5 Hz) | 3.96 (m) | 5.26–5.22 (m) | 4.44 (ddd, 19.5, 10, 4 Hz) | 4.07 (dd, 12.5, 2.5 Hz) | 4.17 (dd, 12.5, 4.5 Hz) | 5.56 (d, 9 Hz) | N–COMe: 1.91 (3H, s) | OCOPr: 2.20–2.42 (8H, m); 1.56–1.75 (8H, m); 0.80–1.00 (12H, m) | ||
6 | 5.69 (d, 9 Hz) | 4.31 (m) | 5.1 (t, 9.5 Hz) | 5.17 (t, 9.5 Hz) | 3.82 (m) | 4.12 (dd, 12.5, 2.5 Hz) | 4.25 (dd, 12.5, 4.5 Hz) | 5.84 (d, 9.5 Hz) | N–COPr: 2.01 (2H, m); 1.57 (2H, dd, 15.75 Hz); 0.88 (3H, t, 7.5 Hz); | O–COMe: 2.01–2.11 (12H, m) | |
7 | α | 6.21 (d, 3.5 Hz) | 4.48 (ddd, 12.5, 9, 1.5 Hz) | 5.21–5.5.29 (m) | 4.01 (m) | 4.07 (d, 11.5 Hz) | 4.23 (dd, 12.5, 4.5 Hz) | 5.72 (d, 8.5 Hz) | N–COPr: 2.05 (2H, m); 1.54 (2H, m). 0.88 (3H, t, 2.5 Hz) | O–COEt: 2.27–2.49 (8H, m); 1.07–1.22 (16H, m) | |
β | 5.73 (d, 9 Hz) | 4.33 (q, 10 Hz) | 3.85 (m) | 6.13 (d, 9.5 Hz) | |||||||
8 | 6.19 (d, 3.5 Hz) | 4.47 (ddd, 13, 9, 1.25 Hz) | 5.24 (quint, 9 Hz) | 3.98–4.01 (m) | 4.07 (dd, 12.5, 2.5 Hz) | 4.22 (dd, 12.5, 4.5 Hz) | 5.53 (d, 8.5 Hz) | N–COMe: 1.92 (3H, s) | O–COEt: 2.25–2.48 (8H, m); 1.09–1.23 (12H, m) | ||
9 | α | 6.18 (d, 3.5 Hz) | 4.43 (ddd, 12.5, 9, 1.5 Hz) | 5.22–5.18 (quint, 10 Hz) | 3.95 (m) | 4.06 (dd, 12.5, 2 Hz) | 4.15 (dd, 12.5, 4.5 Hz) | 5.52 (d, 9 Hz) | NHCOEt: 2.06 (2H, m); 1.04–1.08 (3H, m) | O–COPr: 2.15–2.25 (8H, m); 1.55–1.73 (8H, m); 0.89–0.99 (12H, m) | |
β | 5.67 (d, 8.5 Hz) | 4.3 (m) | 5.13 (quint, 10 Hz) | 3.78 (m) | 4.13 (dd, 12.5, 2.5 Hz) | 4.19 (dd, 12.5, 4.5 Hz) | 5.57 (d, 9 Hz) | ||||
10 | α | 6.29 (d, 3.5 Hz) | 4.70 (dd, 11.5, 3.5 Hz) | 4.35 (dd, 12.5.4 Hz) | 6.54 (dd, 11, 2.5 Hz) | 5.15 (dd, 10.5, 1 Hz) | 4.13 (dd, 12, 2 Hz) | 4.35 (dd, 12.5, 4 Hz) | — | N(CO)2C6H4: 7.83 (2H, m); 7.74 (2H, m) | O–COMe: 1.87–2.12 (9H, s) |
β | 6.51 (d, 9 Hz) | 4.45 (dd, 11.5, 9 Hz) | 4.02 (m) | 5.19 (dd, 10, 1 Hz) | 5.87 (dd, 11.5, 1.5 Hz) | 4.14 (dd, 12, 2.5 Hz) | 4.3 (dd, 12.5; 4 Hz) | — | |||
11 | α | 6.31 (d, 3.5 Hz) | 4.72 (dd, 11.5, 3.5 Hz) | 4.31 (m) | 6.54 (dd, 11.5; 2.5 Hz) | 5.17 (t, 9.5 Hz) | 4.12 (m) | 4.31 (m) | — | N(CO)2C6H4: 7.83 (2H, m); 7.75 (2H, m) | O–COEt: 2.04–2.41 (8H, m); 0.87–1.27 (12H, m) |
β | 6.52 (d, 9 Hz) | 4.46 (dd, 10.5, 1.5 Hz) | 4.06 (m) | 5.24 (t, 9.75 Hz) | 5.89 (dd, 10.5, 1.5 Hz) | — | |||||
12 | α | 6.30 (d, 3.5 Hz) | 4.72 (dd, 11.5, 3.5 Hz) | 4.29 (m) | 6.54 (dd, 11.5, 2.5 Hz) | 5.17 (t, 9.5 Hz) | 4.08 (m) | 4.29 (m) | — | N(CO)2C6H4: 7.82 (2H, m); 7.71 (2H, m) | O–COPr: 2.07–2.35 (8H, m); 1.24–1.62 (8H, m); 0.65–0.98 (12H, m) |
β | 6.52 (d, 9 Hz) | 4.44 (dd, 12, 2 Hz) | 3.8 (m) | 5.22 (t, 9.5 Hz) | 5.9 (dd, 10.5, 1.5 Hz) | 4.08 (m) | 4.29 (m) | — | |||
13 | 6.17 (d, 2.5 Hz) | 4.48 (m) | 5.14–5.27 (m) | 4.0 (d, 9.5 Hz) | 4.05 (d, 12.5 Hz) | 4.23 (dd, 12, 3.5 Hz) | 5.77 (m) | N–COMe: 2.19 (3H, s) | O–COMe: 1.93–2.11 (12H, s) | ||
14 | 6.19 (d, 3.5 Hz) | 4.47 (m) | 5.24 (quint, 9.25 Hz) | 3.99 (m) | 4.07 (d, 7.5 Hz) | 4.22 (dd, 12.5, 4.5 Hz) | 5.55 (m) | N–COEt: 2.44 (2H, q, 7 Hz); 1.21 (3H, t, 7.5 Hz); | OCOEt: 2.09–2.4 (8H, m); 1.07–1.16 (12H, m) | ||
15 | 6.21 (d, 3.5 Hz) | 3.97 (m) | 5.20–5.24 (m) | 4.45 (ddd, 19, 10, 3.5 Hz) | 4.07 (dd, 12.5, 2 Hz) | 4.17 (dd, 2.5, 4.5 Hz) | 5.54 (d, 9 Hz) | N–COPr: 2.04 (2H, m); 1.54 (2H, m); 0.87 (3H, m); | OCOPr: 2.2–2.41 (8H, m); 1.54–1.78 (8H, m); 1.02–0.87 (12H, m) | ||
18 | 5.64 (d, 8.5 Hz) | 3.74 (m) | 5.07–5.18 (m) | 4.26 (m) | 4.07 (dd, 12.5, 2 Hz) | 4.22 (dd, 12.5, 4 Hz) | 6.08 (d, 9.5 Hz) | 1.47 (3H, d, 7 Hz); 3.52 (1H, q, 7 Hz); 7, 4 (1H, dt, 7.5; 3 Hz); 7.48 (3H, m); 7.59 (2H, m); 7.69 (1H, s); 7.78 (2H, dd, 7; 3.5 Hz) | 4 OAc: 1.82–2.06 (12H, s) |
Physical characteristics and ratio of α- and β-isomer of the glucosamine derivatives were showed in Table 2. The α-anomer was preferred for N-acetylated glucosamine with different O-acyl groups such as acetyl, n-propionyl, n-butyryl or even indomethacinyl-substituent.22 With N-phthalated glucosamine, a mixture of the isomers was generated from which derivatives were substituted by shortly fatty groups on the O atom. In exception of the above cases, the β-anomer was preferred for the derivatives containing O-acetyl. The interesting results from Table 2 also showed that penta-acyl-D-glucosamine derivatives (13–15) gave more stable α-stereoisomer. In addition, N-acyl-D-glucosamine derivatives were obtained as a mixture of isomers in which the α-stereoisomer predominated.
N-Acyl groups (or N-substituent) | O-Acyl groups (or O-substituent) | Ratio of isomers | Substances | Mp (°C) | [α]20D (solvent) | Rf (EtOAc![]() ![]() |
|
---|---|---|---|---|---|---|---|
α | β | ||||||
a PE: petroleum ether; EtOAc: ethyl acetate. | |||||||
CH3CO | — | Priority | Lower | 1 | 200–201 | +65 (H2O) | — |
CH3CO | 100% | 0% | 13 | 113–114 | +86.5 (EtOH) | 0.3 (2![]() ![]() |
|
CH3CH2CO | 100% | 0% | 8 | 155–156 | +95.5 (EtOH) | 0.5 (1![]() ![]() |
|
CH3CH2CH2CO | 100% | 0% | 5 | 151–152 | +80 (EtOH) | 0.6 (3![]() ![]() |
|
Indomethacin22 | 100% | 0% | — | — | — | — | |
CH3CH2CO | — | Priority | Lower | 2 | 184–185 | +36 (H2O) | — |
CH3CO23 | 0% | 100% | — | — | — | — | |
CH3CH2CO | 100% | 0% | 14 | 105–106 | +81 (EtOH) | 0.4 (1![]() ![]() |
|
CH3CH2CH2CO | 83% | 27% | 9 | 108–110 | +94 (EtOH) | 0.5 (2![]() ![]() |
|
CH3CH2CH2CO | — | Priority | Lower | 3 | 208–209 | +33 (H2O) | — |
CH3CO | 0% | 100% | 6 | 141–142 | +33 (EtOH) | 0.4 (2![]() ![]() |
|
CH3CH2CO | 59% | 41% | 7 | Liquid | +64 (EtOH) | 0.4 (1![]() ![]() |
|
CH3CH2CH2CO | 100% | 0% | 15 | 94–95 | +65 (EtOH) | 0.5 (1![]() ![]() |
|
C6H4(CO)2 | — | 54% | 46% | 4 | 67–69 | +25 (H2O) | — |
CH3CO | 66% | 34% | 10 | 89–90 | +66 (EtOH) | 0.3 (1![]() ![]() |
|
CH3CH2CO | 66% | 34% | 11 | 50–52 | +117 (EtOH) | 0.5 (1![]() ![]() |
|
CH3CH2CH2CO | 55% | 45% | 12 | 48–49 | +110 (EtOH) | 0.4 (2![]() ![]() |
|
Anisaldehyde | CH3CO | 0% | 100% | 16 | 175–176 | +98 (CHCl3) | 0.4 (1![]() ![]() |
NH2·HCl | CH3CO | 0% | 100% | 17 | 220–222 | +27 (H2O) | - |
Ketoprofen | CH3CO | 0% | 100% | 18 | 134–135 | +7 (CHCl3). | 0.5 (1![]() ![]() |
Sugar moiety | Acyl groups | ||||||||
---|---|---|---|---|---|---|---|---|---|
C-1 | C-2 | C-3 | C-4 | C-5 | C-6 | N-acyl | O-acyl | ||
a NMR experimental conditions: 125 MHz, CDCl3. | |||||||||
5 | 90.44 | 51.30 | 70.40 | 67.20 | 69.96 | 61.43 | 169.76 (C![]() |
172.44; 173.23; 171.24; 171.66 (C![]() |
|
22.99 (CH3) | |||||||||
6 | 92.64 | 52.62 | 72.88 | 67.98 | 72.62 | 61.75 | 172.98 (C![]() |
171.17; 170.64; 169.48; 169.27 (C![]() |
|
38.56 (–COCH2) | |||||||||
19.00 (–CH2CH2) | |||||||||
13.49 (–CH3) | |||||||||
7 | α | 90.41 | 50.94 | 70.43 | 67.30 | 69.74 | 61.39 | 172.03 (C![]() |
175.05; 173.97; 172.83; 172.49 (C![]() |
38.19 (COCH2) | |||||||||
18.79 (–CH2CH2) | |||||||||
13.36 (–CH3) | |||||||||
β | 92.51 | 52.48 | 72.42 | 67.68 | 72.85 | 61.50 | 172.91 (C![]() |
174.48; 172.87; 172.63 (C![]() |
|
38.41 (COCH2) | |||||||||
18.90 (–CH2CH2) | |||||||||
18.38 (–CH3) | |||||||||
8 | 90.60 | 51.21 | 70.62 | 67.34 | 69.88 | 61.45 | 169.80 (C![]() |
172.09; 172.55; 174.06; 175.25 (C![]() |
|
22.99 (COCH3) | |||||||||
9 | α | 90.46 | 51.21 | 70.44 | 67.21 | 69.98 | 61.45 | 171.21 (C![]() |
174.44; 173.48; 173.22; 171.66 (C![]() |
29.47 (COCH2) | |||||||||
9.49 (CH3) | |||||||||
β | 92.66 | 52.87 | 73.14 | 67.44 | 72.35 | 61.46 | 171.22 (C![]() |
171.66; 173.23; 173.49; 173.77 (C![]() |
|
29.69 (COCH2) | |||||||||
9.63 (CH3) | |||||||||
10 | α | 90.52 | 52.84 | 70.19 | 67.04 | 69.42 | 61.53 | 167.39 (C![]() |
170.63; 169.99; 169.75; 169.49; 169.44; 169.28; 168.60 (C![]() |
134.44 (CH) | |||||||||
131.17 (C) | |||||||||
123.71 (CH) | |||||||||
β | 89.80 | 53.53 | 70.53 | 68.36 | 72.66 | 61.56 | |||
11 | α | 90.43 | 52.90 | 70.29 | 66.84 | 69.21 | 61.39 | 167.31 (C![]() |
174.00; 173.37; 173.08; 172.83172.74; 172.03 (C![]() |
134.37 (CH) | |||||||||
132.12 (C) | |||||||||
123.58 (CH) | |||||||||
β | 89.72 | 53.60 | 68.16 | 65.75 | 72.83 | 60.29 | |||
12 | α | 90.33 | 52.97 | 70.30 | 66.82 | 69.10 | 60.38 | 167.33 (C![]() |
173.21; 172.50; 172.20; 171.95; 171.93; 171.82; 171.19; 171.08 (C![]() |
134.39 (CH) | |||||||||
131.26 (C) | |||||||||
123.59 (CH) | |||||||||
β | 89.67 | 53.71 | 70.20 | 68.13 | 72.80 | 61.43 | |||
13 | 90.61 | 51.00 | 70.61 | 67.56 | 69.66 | 61.53 | 171.55 (C![]() |
170.57; 169.99; 169.02; 168.57 (C![]() |
|
20.44 (CH3) | |||||||||
14 | 90.60 | 51.09 | 70.61 | 67.32 | 69.88 | 61.47 | 172.08 (C![]() |
175.18; 174.05; 173.55; 172.55 (C![]() |
|
29.49 (COCH2) | |||||||||
9.57 (CH3) | |||||||||
15 | 90.44 | 51.25 | 70.40 | 67.26 | 70.00 | 61.48 | 174.48 (C![]() |
173.27; 172.73; 171.71; 171.24 (C![]() |
|
18.28 (–COCH2) | |||||||||
35.89 (–CH2CH2) | |||||||||
13.55 (–CH3) | |||||||||
18 | 92.31 | 52.92 | 67.86 | 72.43 | 72.84 | 61.66 | 18.12 (CH3); 46.95 (CH); 128.36 (2C; CH); 128.59 (CH); 129.0 (CH); 129.18 (CH); 130.05 (2C, CH); 131.15 (CH); 132.63 (CH); 137.32 (C); 138.03 (C); 141.34 (C); 173.67 (C![]() ![]() |
169.25; 169.42; 170.61; 170.94 (C![]() |
Analysis of the NMR spectra of compounds 7 and 9 showed that the H-1 signal of α-anomer appeared at higher δ values than the H-1 signal of β-anomer, owing to their different equatorial and axial orientations (Δδ ∼ 0.5 ppm). Meanwhile, the C-1 carbon atom of the α-anomer resonated at higher field than of the β-anomer (Δδ ∼ 2.1 ppm). Especially, the H-1 chemical shifts of the α-anomer of N,N-phthaloyl glucosamine derivatives were lower than chemical shifts of the β-anomer. This showed that influence of two carbonyl groups (CO) and benzene ring in N,N-phthaloyl glucosamine structure caused deshielding of H-1 in the β-anomer (Δδ ∼ 0.22 ppm) in comparison with the corresponding H-1 signal of the α-anomer. In this case, the C-1 carbon atom of the α-anomer resonated at lower fields than C-1 carbon atom of the β-anomer (Δδ ∼ 0.7 ppm). Interestingly, the various N-acyl substituted groups had a significant influence on the resonance frequency of the sugar ring protons and carbons.
Analysis of the NMR spectra of 1–4 confirmed the empirical rules in the NMR spectroscopy of carbohydrates. Firstly, the axial orientation of the anomeric OH group in the α-anomer caused absorption at higher δ values of equatorially oriented H-1 protons in comparison with the corresponding β-anomer (Δδ ∼ 0.5 ppm). The C-1 carbon atom of the β-anomer resonated at lower fields than the C-1 carbon atom of the α-anomer (Δδ ∼ 4 ppm). These were compatible with the previous report.26 Moreover, the C-2 carbon atom of the β-anomer was deshielded in comparison with the corresponding C-2 carbon atom of the α-anomer (Δδ ∼ 2.5 ppm).
A round-bottomed flask equipped with a three-way stopcock was heated under reduced pressure and then cooled room temperature under a nitrogen atmosphere. The above intermediate (22.3 g, 75.03 mmol) and pyridine (120 mL) were placed in the flask. After cooling down to 0 °C, acetic anhydride (12.5 mL) was added under stirring via a syringe. The mixture was stirred at 0 °C during 2 h and stirring was continued at room temperature overnight. The reaction was ended by adding 500 mL the water at 0 °C. The residue was collected by suction filtration, washed with the cold water and dried in vacuo to give 16 as a white solid (28.7 g, 83.87%). 1H NMR (500 MHz, CDCl3) δ 7.65 (2H, dd, J = 7.0, 2.0 Hz), 6.92 (2H, dd, J = 9.0, 2.0 Hz), 5.93 (1H, d, J = 8 Hz), 5.43 (1H, t, 10 Hz), 5.14 (1H, t, J = 10 Hz), 4.36 (1H, dd, J = 12.5, 4.5 Hz), 4.12 (1H, dd, J = 12.5, 2.5 Hz), 3.96 (1H, m), 3.84 (3H, s), 3.43 (1H, dd, J = 10.0, 8.0 Hz), 2.13–1.88 (12H, s). 13C NMR (125 MHz, CDCl3) δ 170.68, 169.89, 169.54, 168.76, 164.27, 130.27, 128.35, 114.09, 93.20, 73.30, 72.98, 72.81, 68.11, 61.87, 55.42, 20.81, 20.76, 20.68, 20.51.
A round-bottomed flask equipped with a three-way stopcock was heated under reduced pressure and then cooled room temperature under a nitrogen atmosphere. Ketoprofen (1.0 g, 3.9 mmol) in dry DMF (15 mL) and DCC (1.22 g, 5.8 mmol) were placed in the flask and the mixture was stirred at 0 °C. Into the flask was added 1,3,4,6-tetra-O-acetylglucosamine (0.5 g, 1.5 mmol) in dry DMF via a syringe. The whole was stirred at 0 °C for 4 h and stirring was continued at room temperature overnight. The mixture was diluted by ethyl acetate and then the solid was filtered off. Ethyl acetate layer was washed with water, dried over anhydrous MgSO4 and concentrated under reduced pressure. The pure product 18 was recrystallized in diethyl ether as a white solid (0.44 g, 51.5%).
Footnote |
† Electronic supplementary information (ESI) available: 1D and 2D NMR data of novel compounds. See DOI: 10.1039/c3ra46007j |
This journal is © The Royal Society of Chemistry 2014 |